MELISSA OSEGUERA: Open Payments
NPI 1558945378 · HOBART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$390 in 14 payments from 7 companies in 2025. Trend: 2023 $22 · 2024 $259 · 2025 $390
Food & beverage: $390
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $101 |
| Corium, LLC | 1 | $88 |
| Indivior Inc. | 3 | $57 |
| Orexo US, Inc. | 3 | $44 |
| ABBVIE INC. | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Braeburn Inc. | 2 | $31 |
Products named: REXULTI, Azstarys, SUBLOCADE, Zubsolv, VRAYLAR, RELISTOR, BRIXADI.
Industry payments across IN — which companies pay providers there.
